Discussion of Field Effects After Intraovarian Injection of Autologous Platelet-Rich Plasma
April 2023
in “
Bulletin of the National Research Centre
”
New to Platelet-Rich Plasma? There is a guide in the encyclopedia. Read the guide → 
Studysummary This review discusses the potential use of autologous platelet-rich plasma to enhance ovarian reserve by interacting with follicles and other ovarian components, and it reports no new clinical results.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The document discusses the potential of autologous platelet-rich plasma (PRP) as an alternative treatment to improve ovarian reserve in pre-menopausal women. It suggests that intraovarian PRP may interact not only with follicles or oocyte precursors but also with other ovarian components like stroma, perivascular cells, immune cells, granulosa cells, and endothelium that respond to platelet cytokines. The study indicates that PRP could influence the ovarian microclimate, potentially affecting follicle assembly and oocyte competency. However, the document concludes that further research is needed to understand the specific ovarian stromal responses following PRP and calls for standardization in PRP processing techniques and injection methods to increase its clinical use.
